BURATO, GIULIA
 Distribuzione geografica
Continente #
EU - Europa 116
NA - Nord America 106
AS - Asia 67
SA - Sud America 5
AF - Africa 4
OC - Oceania 1
Totale 299
Nazione #
US - Stati Uniti d'America 105
IT - Italia 31
CN - Cina 30
GB - Regno Unito 26
SG - Singapore 22
RU - Federazione Russa 20
DE - Germania 12
SE - Svezia 10
IE - Irlanda 7
BR - Brasile 5
HK - Hong Kong 5
FI - Finlandia 4
VN - Vietnam 4
FR - Francia 3
KR - Corea 3
EG - Egitto 2
AU - Australia 1
ID - Indonesia 1
IL - Israele 1
IN - India 1
LV - Lettonia 1
MA - Marocco 1
MX - Messico 1
RS - Serbia 1
SC - Seychelles 1
UA - Ucraina 1
Totale 299
Città #
Southend 25
Chandler 18
Verona 13
Ashburn 8
Dublin 7
Jacksonville 7
Singapore 7
Dallas 6
Falls Church 5
Hong Kong 5
Houston 5
Milan 5
Moscow 5
Los Angeles 4
Hebei 3
Helsinki 3
New York 3
Taizhou 3
Wilmington 3
Beijing 2
Bitonto 2
Buffalo 2
Cairo 2
Dearborn 2
Dong Ket 2
Haikou 2
Jinan 2
Lawrence 2
Ningbo 2
Phoenix 2
Princeton 2
San Francisco 2
Seoul 2
The Dalles 2
Tianjin 2
Barra Mansa 1
Belgrade 1
Bergamo 1
Boardman 1
Canberra 1
Catania 1
Columbus 1
Council Bluffs 1
Cubatão 1
Düsseldorf 1
Guarabira 1
Guiyang 1
Hefei 1
Ilha Comprida 1
Jakarta 1
Jerusalem 1
Kent 1
Lanzhou 1
Las Vegas 1
Ludwigshafen 1
Mahé 1
Marrakesh 1
Mexico City 1
Munich 1
Nanchang 1
Nanjing 1
Naples 1
Norwalk 1
Nuremberg 1
Palermo 1
Pasadena 1
Riga 1
Santa Clara 1
Seattle 1
Sindelfingen 1
Taiyuan 1
Teresina 1
Vicenza 1
Woodbridge 1
Xiangfen 1
Totale 207
Nome #
LC3B and ph-S6K are both expressed in epithelioid and classic renal angiomyolipoma: a rationale tissue-based evidence for combining use of autophagic and mTOR targeted drugs 181
The presence of poorly differentiated clusters predicts survival in stage II colorectal cancer 129
Totale 310
Categoria #
all - tutte 1.049
article - articoli 1.049
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.098


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202113 0 0 0 0 2 3 1 0 0 1 2 4
2021/202231 2 9 0 1 3 5 2 0 2 0 2 5
2022/202350 2 8 3 7 3 12 3 6 5 0 0 1
2023/202428 1 4 2 3 1 6 1 0 0 2 6 2
2024/202556 2 3 2 12 3 2 0 13 8 2 5 4
2025/202650 9 5 10 21 5 0 0 0 0 0 0 0
Totale 310